Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

082024-11

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASE AGREEMENT
012024-11

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
022024-10

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
272024-09

2024 INTERIM REPORT
022024-09

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
282024-08

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
162024-08

NOTICE OF BOARD MEETING
012024-08

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
022024-07

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
032024-06

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
202024-05

ANNOUNCEMENT ON ELECTION OF EMPLOYEE REPRESENTATIVE SUPERVISOR
202024-05

(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023

1 2 3 4 5

The Enterprise OA